These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 32201689)

  • 21. Factors associated with
    Jiang Y; Chen J; Ying M; Liu L; Li M; Lu S; Li Z; Zhang P; Xie Q; Liu X; Lu H
    Front Med (Lausanne); 2023; 10():1136094. PubMed ID: 37181365
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predictors of Loss to Follow-Up among Men with Tuberculosis in Puducherry and Tamil Nadu, India.
    Zhou TJ; Lakshminarayanan S; Sarkar S; Knudsen S; Horsburgh CR; Muthaiah M; Kan CK; Salgame P; Ellner JJ; Roy G; Jenkins HE; Hochberg NS
    Am J Trop Med Hyg; 2020 Sep; 103(3):1050-1056. PubMed ID: 32618243
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Effect of Timing of Initiation of Antiretroviral Therapy on Loss to Follow-up in HIV-Tuberculosis Coinfected Patients in South Africa: An Open-Label, Randomized, Controlled Trial.
    Yende-Zuma N; Naidoo K
    J Acquir Immune Defic Syndr; 2016 Aug; 72(4):430-6. PubMed ID: 26990824
    [TBL] [Abstract][Full Text] [Related]  

  • 24. What happened to patients with RMP-resistant/MDR-TB in Zambia reported as lost to follow-up from 2011 to 2014?
    Kasapo CC; Chimzizi R; Simwanza SC; Mzyece J; Chizema E; Mariandyshev A; Lee HY; Harries AD; Kapata N
    Int J Tuberc Lung Dis; 2017 Aug; 21(8):887-893. PubMed ID: 28786797
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Who will be lost? Identifying patients at risk of loss to follow-up in Malawi. The DREAM Program Experience.
    Mancinelli S; Nielsen-Saines K; Germano P; Guidotti G; Buonomo E; Scarcella P; Lunghi R; Sangare H; Orlando S; Liotta G; Marazzi MC; Palombi L
    HIV Med; 2017 Sep; 18(8):573-579. PubMed ID: 28150466
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Microbiologically Confirmed Tuberculosis: Factors Associated with Pre-Treatment Loss to Follow-Up, and Time to Treatment Initiation.
    Mwansa-Kambafwile J; Maitshotlo B; Black A
    PLoS One; 2017; 12(1):e0168659. PubMed ID: 28068347
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Determinant factors for loss to follow-up in drug-resistant tuberculosis patients: the importance of psycho-social and economic aspects.
    Soedarsono S; Mertaniasih NM; Kusmiati T; Permatasari A; Juliasih NN; Hadi C; Alfian IN
    BMC Pulm Med; 2021 Nov; 21(1):360. PubMed ID: 34758794
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hidden loss to follow-up among tuberculosis patients managed by public-private mix institutions in South Korea.
    Kim HW; Park S; Min J; Sun J; Shin AY; Ha JH; Park JS; Lee SS; Lipman M; Abubakar I; Stagg HR; Kim JS
    Sci Rep; 2022 Jul; 12(1):12362. PubMed ID: 35859107
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predictors of lost to follow-up in a "test and treat" programme among adult women with high-risk sexual behavior in Kampala, Uganda.
    Kamacooko O; Mayanja Y; Bagiire D; Namale G; Hansen CH; Seeley J
    BMC Public Health; 2020 Mar; 20(1):353. PubMed ID: 32183759
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of TB patient delay on loss to follow-up in Portugal.
    Marques J; Rocha JV; Soares P; Leite A; Duarte R; Nunes C
    Int J Tuberc Lung Dis; 2023 Jul; 27(7):537-542. PubMed ID: 37353867
    [No Abstract]   [Full Text] [Related]  

  • 31. Nationwide analysis of treatment outcomes in children and adolescents routinely treated for tuberculosis in the Netherlands.
    Gafar F; Van't Boveneind-Vrubleuskaya N; Akkerman OW; Wilffert B; Alffenaar JC
    Eur Respir J; 2019 Dec; 54(6):. PubMed ID: 31515410
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rifampicin-resistant tuberculosis patients in Myanmar in 2016: how many are lost on the path to treatment?
    Htet KKK; Soe KT; Kumar AMV; Saw S; Win Maung HM; Myint Z; Khine TMM; Aung ST
    Int J Tuberc Lung Dis; 2018 Apr; 22(4):385-392. PubMed ID: 29562985
    [TBL] [Abstract][Full Text] [Related]  

  • 33. From DOTS to the Stop TB Strategy: DOTS coverage and trend of tuberculosis notification in Ebonyi, southeastern Nigeria, 1998-2009.
    Ukwaja K; Alobu I; Ifebunandu N; Osakwe C; Igwenyi C
    Pan Afr Med J; 2011; 9():12. PubMed ID: 22145056
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Unfavourable outcomes among patients with MDR-TB on the standard 24-month regimen in Maharashtra, India.
    Suryawanshi SL; Shewade HD; Nagaraja SB; Nair SA; Parmar M
    Public Health Action; 2017 Jun; 7(2):116-122. PubMed ID: 28695084
    [No Abstract]   [Full Text] [Related]  

  • 35. Bacteriologically confirmed pulmonary tuberculosis patients: Loss to follow-up, death and delay before treatment initiation in Bulawayo, Zimbabwe from 2012-2016.
    Mugauri H; Shewade HD; Dlodlo RA; Hove S; Sibanda E
    Int J Infect Dis; 2018 Nov; 76():6-13. PubMed ID: 30030177
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluating the impact of the nationwide public-private mix (PPM) program for tuberculosis under National Health Insurance in South Korea: A difference in differences analysis.
    Yu S; Sohn H; Kim HY; Kim H; Oh KH; Kim HJ; Chung H; Choi H
    PLoS Med; 2021 Jul; 18(7):e1003717. PubMed ID: 34260579
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Trends of tuberculosis case detection, mortality and co-infection with HIV in Ghana: A retrospective cohort study.
    Osei E; Oppong S; Der J
    PLoS One; 2020; 15(6):e0234878. PubMed ID: 32579568
    [TBL] [Abstract][Full Text] [Related]  

  • 38. FACTORS CONTRIBUTING TO PULMONARY TB TREATMENT LOST TO FOLLOW-UP IN DEVELOPING COUNTRIES: AN OVERVIEW.
    Monique O; Ilse DP
    Afr J Infect Dis; 2023; 17(1):60-73. PubMed ID: 36756489
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment outcomes of TB-infected individuals attending public sector primary care clinics in rural Liberia from 2015 to 2017: a retrospective cohort study.
    Wickett E; Peralta-Santos A; Beste J; Micikas M; Toe F; Rogers J; Jabateh L; Wagenaar BH
    Trop Med Int Health; 2018 May; 23(5):549-557. PubMed ID: 29524302
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.